Amikacin pharmacokinetics during continuous ambulatory peritoneal dialysis.
The pharmacokinetics of amikacin were investigated in five stable patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Each patient was studied after the administration of 7.5 mg of amikacin per kg by both the intravenous (i.v.) and intraperitoneal (i.p.) route, allowing a 1-month w...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1988
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172141/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3364945/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.2.236 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|